First-line treatment with bevacizumab in patients with metastatic colorectal cancer: the significance of EGFR pathway mutations for efficacy.
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2015
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Colorectal cancer
- Focus Therapeutic Use
- 10 Aug 2015 New trial record